Assignee
HANGZHOU SOLIPHARMA CO LTD
CN·18 granted patents·3 pending applications·7 citations·filing 2015–2023
Top patents by PatentIndex Score
21 records- 0188US10899770B2Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Jan 26, 2021·4 cites·14 claims
- 0275US10899767B2Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Jan 26, 2021·1 cites·7 claims
- 0372US10669256B2Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Jun 2, 2020·1 cites·28 claims
- 0471US10954223B2Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2019·Granted Mar 23, 2021·0 cites·6 claims
- 0571US10954210B2Crystal form of tipifarnib and preparation method and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Mar 23, 2021·1 cites·24 claims
- 0668US11919906B2Crystal form of ACP-196 and method of treatment thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2020·Granted Mar 5, 2024·0 cites·20 claims
- 0765US12103925B2Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2023·Granted Oct 1, 2024·0 cites·24 claims
- 0865US2021163457A1Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0964US10660963B2Pharmaceutical composition containing tacrolimus and preparation methods thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Granted May 26, 2020·0 cites·14 claims
- 1060US11286259B2Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Granted Mar 29, 2022·0 cites·27 claims
- 1160US2024270733A1Hydrate form of lazertinib mesylate, preparation method thereof and use thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1259US11236077B2Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·29 claims
- 1357US11639341B2Crystal form of tipifarnib and method of treatment thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2020·Granted May 2, 2023·0 cites·24 claims
- 1457US11236073B2ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Feb 1, 2022·0 cites·20 claims
- 1554US11208382B2Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Dec 28, 2021·0 cites·12 claims
- 1653US11111248B2Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·20 claims
- 1748US10995083B2Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical compositionHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted May 4, 2021·0 cites·14 claims
- 1845US10759798B2ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Sep 1, 2020·0 cites·21 claims
- 1944US11117875B2Crystalline forms, preparation methods and pharmaceutical compositions of ozanimodHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Sep 14, 2021·0 cites·17 claims
- 2041US10675276B2Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2015·Granted Jun 9, 2020·0 cites·16 claims
- 2141US2021179585A1Crystal form of abemaciclib mesylate, preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANGZHOU SOLIPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →